Hottest Online News Portal

Viagra For Women May Be Released This Week

in Latest/Woman

We’re all too aware women sometimes need a libido boost beyond roses, chocolates and the cast of “Magic Mike XXL.” Sexual dysfunction is a controversial subject, with many people pointing out that stigma, stress and sexual violence against women are all issues that need to be addressed first.

As such, female product for sexual dysfunction has lagged far behind development of male products — namely Viagra, which was approved by the FDA in 1998.

According to the Washington Post, the Food and Drug Administration is expected to decide this week whether to approve “Viagra for women” – officially called flibanserin.

In June, an FDA advisory panel voted 18-6 to recommend that the FDA approve the drug. As CNN explains, the approval applies to women with “hypoactive sexual desire disorder,” or a lack of sexual desire, in women before menopause.

Ladies, here’s what you need to know about when you can start popping the new pills – and whether you even should:

1. Flibanserin is intended for women “whose lack of sexual desire was not attributable to other causes such as disease or relationship troubles,” says the New York Times. In other words, flibanserin obviously cannot address underlying relationship issues putting a damper on your sex life.

2. Before the drug hits shelves, the FDA is working to limit certain risks. The Times reports that doctors may have to be certified to prescribe the drug. At minimum, users should be wary of potential side effects like low blood pressure, fainting, nausea and dizziness.

3. Unlike Viagra, which is taken before sex, flibanserin will need to be taken once a day at bedtime. It will alter the brain chemicals that lead to arousal, like serotonin and dopamine (similar to antidepressants).

4. The drug could help more than 10% of American women who have a lack of sexual desire that causes them distress, says CNBC.

5. Flibanserin has been rejected by advisory committees twice – once unanimously. Activists, united under a campaign called “Even the Score,” claim the FDA is biased against women who have none of men’s many routes to medical-induced sexual potency.

6. Several of the committee members voted “yes” while still concerned about the drug’s side effects, meaning whether or not the drug will hit shelves is still up in the air.

7. The stock price of Palatin Technologies, who manufactures a similar “female desire medication” that is seeking FDA approval, soared 46 percent in JUne.

8. The pill is pink. Obviously.

Tags:

Latest from Latest

Go to Top